Navigation Links
P\S\L Group appoints Paul Barnes as Group President P\S\L Research

NEW YORK, Feb. 7 /PRNewswire/ -- P\S\L Group is pleased to announce the appointment of Paul Barnes to the newly created position of Group President for P\S\L Research (PSLR).

In his new role, Mr. Barnes will lead the P\S\L Research Group, which consists of all existing research businesses: P\S\L Research International, P\S\L Research Europe and P\S\L Research Canada. His focus will be to ensure that the existing research businesses continue to realize their full potential, and also to develop new research and consulting services to support specific market-focused client needs.

"With the creation of Business Groups, P\S\L is providing a framework for continued growth of the network of research, medical information and education businesses," states Michele Fearon, CEO P\S\L Group. "This structure will create an executive management team for each major business field and establish the environment and infrastructure to encourage the emergence of several new business units, each focused on leveraging P\S\L Group assets. We are delighted to welcome Paul to the organization."

Mr. Barnes brings 20 years of global market research experience in the pharmaceutical industry. He has spent the past 12 years at TNS, one of the largest healthcare market research agencies worldwide, where most recently he was president for TNS' US healthcare unit. Earlier in his career he worked in sales and marketing on the client side with Glaxo and Lederle.

"P\S\L Group has a strong and unique combination of research and information assets to support pharmaceutical clients," commented Mr. Barnes. "I am very excited about joining such a dynamic organization and look forward to working with the very talented team in the P\S\L Research Group."

Mr. Barnes will be based in the P\S\L US head office located at 24 W. 40th Street, Suite 800, New York, NY, 10018.

About P\S\L Group

P\S\L Group is a global organization dedicated to putting information at the service of medicine. The companies and people of the P\S\L Group aim to improve medical care by serving those who need it, those who provide it and those who seek to improve it.

P\S\L Group business purpose and strategic intent

P\S\L Group clients include research-based pharmaceutical companies and other healthcare institutions who seek the advancement of medicine. Our primary business purpose is to help these clients increase the effectiveness, as well as lower the cost, of activities pertaining to scientific communication, medical education or product/service marketing.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Google, Yahoo Personal Trainers Strengthen Digital Delts, Partner With Saatchi & Saatchi Healthcare Communications Group Teams in Tech Circuit Training
2. National Business Group on Health to Hold Press Conference to Announce Partnership to Eliminate Racial and Ethnic Health Disparities
3. The Ensign Group, Inc. Announces the Appointment of Covey C. Christensen as President of Its Flagstone Subsidiary
4. Texas Senator Tommy Williams Honored as Champion for Children by the AMERIGROUP Foundation
5. STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
6. Dr. Richard Merkin & Heritage Victor Valley Medical Group to Host Victorville Senior Valentines Day Luncheon
7. Movement Against Cancer, a Cancer Patient Advocacy Group in Russia, Launches an Effort to Inform Russian Authorities and the Public About Inadequate Access of Innovative and Effective Cancer Treatments for Cancer Patients in Russia
8. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
9. Bush Budget Puts Future of Health Care for All Children in Jeopardy, According to National Pediatric Groups
10. Heritage Valley Health System Named a Finalist for Microsoft Healthcare User Group Award
11. AMERIGROUP Foundation Announces Winners of Word About Health Contest
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: